Welcome to LookChem.com Sign In|Join Free

CAS

  • or

860624-88-0

Post Buying Request

860624-88-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

860624-88-0 Usage

Description

5-BROMO-INDOLINE-7-CARBOXYLIC ACID METHYL ESTER is a chemical compound with the molecular formula C10H9BrN2O2. It is a methyl ester derivative of 5-bromo-indoline-7-carboxylic acid, which is commonly used in the synthesis of pharmaceutical and agrochemical compounds. 5-BROMO-INDOLINE-7-CARBOXYLIC ACID METHYL ESTER has potential applications in organic synthesis and medicinal chemistry, as it can serve as a building block for the production of various biologically active molecules. Its unique structure and properties make it a valuable tool for researchers and chemists working in the field of drug discovery and development.

Uses

Used in Pharmaceutical Industry:
5-BROMO-INDOLINE-7-CARBOXYLIC ACID METHYL ESTER is used as a building block for the synthesis of pharmaceutical compounds, due to its potential to produce biologically active molecules.
Used in Agrochemical Industry:
5-BROMO-INDOLINE-7-CARBOXYLIC ACID METHYL ESTER is used as a building block for the synthesis of agrochemical compounds, contributing to the development of new pesticides or other agricultural products.
Used in Organic Synthesis:
5-BROMO-INDOLINE-7-CARBOXYLIC ACID METHYL ESTER is used as a reagent in organic synthesis, enabling the creation of a variety of chemical structures for research and commercial purposes.
Used in Medicinal Chemistry:
5-BROMO-INDOLINE-7-CARBOXYLIC ACID METHYL ESTER is used as a research tool in medicinal chemistry, aiding in the discovery and development of new drugs and therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 860624-88-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,0,6,2 and 4 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 860624-88:
(8*8)+(7*6)+(6*0)+(5*6)+(4*2)+(3*4)+(2*8)+(1*8)=180
180 % 10 = 0
So 860624-88-0 is a valid CAS Registry Number.

860624-88-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 5-bromo-2,3-dihydro-1H-indole-7-carboxylate

1.2 Other means of identification

Product number -
Other names 5-bromo-2,3-dihydro-indole-7-carboxylic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:860624-88-0 SDS

860624-88-0Relevant articles and documents

3,5-Disubstituted-indole-7-carboxamides as IKKβ Inhibitors: Optimization of Oral Activity via the C3 Substituent

Kerns, Jeffrey K.,Busch-Petersen, Jakob,Fu, Wei,Boehm, Jeffrey C.,Nie, Hong,Muratore, Michael,Bullion, Ann,Lin, Guoliang,Li, Huijie,Davis, Roderick,Lin, Xichen,Lakdawala, Ami S.,Cousins, Rick,Field, Rita,Payne, Jeremy,Miller, David D.,Bamborough, Paul,Christopher, John A.,Baldwin, Ian,Osborn, Ruth R.,Yonchuk, John,Webb, Edward,Rumsey, William L.

supporting information, p. 1164 - 1169 (2018/11/23)

IκB kinase β (IKKβ or IKK2) is a key regulator of nuclear factor kappa B (NF-κB) and has received attention as a therapeutic target. Herein we report on the optimization of a series of 3,5-disubstituted-indole-7-carboxamides for oral activity. In doing so

3,5-Disubstituted-indole-7-carboxamides: The discovery of a novel series of potent, selective inhibitors of IKK-β

Miller, David D.,Bamborough, Paul,Christopher, John A.,Baldwin, Ian R.,Champigny, Aurelie C.,Cutler, Geoffrey J.,Kerns, Jeffrey K.,Longstaff, Timothy,Mellor, Geoffrey W.,Morey, James V.,Morse, Mary A.,Nie, Hong,Rumsey, William L.,Taggart, John J.

scheme or table, p. 2255 - 2258 (2011/05/15)

The discovery and hit-to-lead exploration of a novel series of selective IKK-β kinase inhibitors is described. The initial lead fragment 3 was identified by pharmacophore-directed virtual screening. Homology model-driven SAR exploration of the template le

INDOLE CARBOXAMIDES AS IKK2 INHIBITORS

-

Page/Page column 68-69, (2008/12/04)

The invention is directed to novel indole carboxamide compounds. Specifically, the invention is directed to compounds according to formula (I): wherein R1, R2, R3, R4, and m are as defined herein. The compounds of the invention are inhibitors of IKK2 and can be useful in the treatment of disorders associated with inappropriate IKK2 (also known as IKKβ) activity, such as rheumatoid arthritis, asthma, rhinitis, and COPD (chronic obstructive pulmonary disease). Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting IKK2 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 860624-88-0